QioMed Generates GCPR Structures for Drug Discovery and Design

  • GPCR tertiary structures and binding site determination

  • GPCR active conformation structures necessary for drug design

  • Design of high-affinity and innovative ligands and leads

  • Design leads for specificity to target to minimize or avoid side effects

  • In silico receptor screening against large compound databases

QioMed’s proven bio-computational technology rapidly provides accurate structures not otherwise available.  QioMed’s unique process provides these structures and insights to anchor a more productive drug discovery and development experience.  Pre-existing experimental data is helpful but not required.

QioMed can generate similar results for GPCR and non-GPCR protein targets.